Navigation Links
Marrone Bio Innovations Named an IC20 Company
Date:11/18/2009

DAVIS, Calif., Nov. 18 /PRNewswire/ -- Marrone Bio Innovations (MBI), a leader in the discovery, development and commercialization of effective and environmentally responsible pest management products, announced that it has been named an IC20 company by the Investors' Circle, the United States' oldest and largest national angel investing group.

Companies named to the IC20 excel in performance leading to rewarding results for all stakeholders, including investors, the environment and society. Qualitative and quantitative metrics are used to assess 197 companies, identifying the top achievers in financial, social, and environmental success.

"MBI's selection as an IC20 company recognizes our commitment to bringing effective, natural, environmentally sound pest management products to the marketplace," states Pam Marrone, Founder and CEO of MBI. "Our success comes from solving our customers unmet needs, and providing safe, effective products to replace and augment disappearing synthetic alternatives. Our mission inherently benefits the environment, and our success rewards those who have contributed financially to our growth and achievements, such as the Investors' Circle."

Marrone Bio Innovations (MBI) discovers, develops and markets effective and environmentally responsible products that fill unmet needs for weed, disease and pest management. MBI's effective and safe products come from a combination of in-licensed technology and its own discovery. The company's own R&D finds naturally occurring microorganisms from unique habitats and develops them into pest management products. MBI has an impressive pipeline of new products, including two insecticides, two herbicides and Zequanox(TM), a product for controlling invasive zebra and quagga mussels in fresh waterways. MBI currently markets Regalia® for control of fungal and bacterial diseases of both food and ornamental crops, and GreenMatch® Burndown Herbicide for weed control in organic crop production.

Investors' Circle is a network of over 225 angel investors, professional venture capitalists, foundations, family offices and others who are using private capital to promote the transition to a sustainable economy. Since 1992, Investors' Circle has facilitated the flow of over $133 million into more than 200 companies and small funds addressing social and environmental issues.

SOURCE Marrone Bio Innovations


'/>"/>
SOURCE Marrone Bio Innovations
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Glycos Biotechnologies, Inc. Selected to Present at Alternative Energy Innovations 2009
2. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 27, 2009 to Discuss Third Quarter 2009 Results
3. The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations
4. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
5. Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
6. Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements.
7. Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations
8. Carbon Design Innovations, Inc. Introduces Carbon Nanotube Probe Technology for Atomic Force Microscopy, CNT-Probes Deliver New Level of AFM Imaging Performance
9. Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
10. Health Care Innovations and Opportunities Attract Attendees from 40 Countries and Delegations from 12 to 6th Annual World Health Care Congress
11. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Dermata Therapeutics, ... products to treat a variety of dermatological diseases, ... Series 1a financing and entered into a $5 ...  Dermata intends to use the capital for general ... major advancements in the treatment of serious diseases ...
(Date:2/16/2017)... ... February 16, 2017 , ... AxioMed announced today the success ... trained surgeon, completed the procedure on Monday, Jan. 30 at Andrews Memorial Hospital ... suffering from degenerative disc disease with radiculomyelopathy, as a result of degenerative cervical ...
(Date:2/16/2017)... Feb. 16, 2017  Rhythm, a biopharmaceutical ... deficiencies that result in life-threatening metabolic disorders, ... million mezzanine round of financing with existing ... Capital, New Enterprise Associates, Pfizer Venture Investments, ... healthcare investment fund. Rhythm will use the ...
(Date:2/16/2017)... ... February 16, 2017 , ... ... Inc. has further extended its industry leading Biochemistry Services specifically targeting the ... cGMP techniques and methods for the biochemical and biosimilar characterization , ...
Breaking Biology Technology:
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
(Date:1/23/2017)...  The latest mobile market research from Acuity Market ... The quarterly average price of a biometric smartphone decreased ... 2016.  There are now 120 sub-$150 models on the ... just 28 a year ago at an average price ... Most , Acuity Market Intelligence Principal, "Biometric Smartphones are ...
(Date:1/18/2017)... MedNet Solutions , an innovative ... spectrum of clinical research, is proud to announce ... the organization in terms of corporate growth, outside ... and services. The company,s exceptional achievements can be ... iMedNet ™ – MedNet,s ...
Breaking Biology News(10 mins):